221759 RESULTS

Pimavanserin Phase 2 Trial Data Published

RESEARCH NEWS 2018-02-23 Research News In 2016, the FDA approved the serotonin-boosting antipsychotic pimavanserin  to treat hallucinations and delusions associated with Parkinson’s disease psychosis. Would the drug curb these symptoms in people with Alzheimer’s, a disease with a ...

Jacques Nunez, Tau Pioneer, Dies at 90

COMMUNITY NEWS 2018-02-23 Community News The Alzheimer’s field has lost another pioneer with the passing of Jacques Nunez, who died February 10. For most of his career, Nunez was a biochemist at INSERM in France, where he studied tau and MAP2 in axonal and dendritic growth. He is ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From